Why does intensive insulin therapy implemented at the onset of type 1 diabetes not decrease prevalence of diabetic microangiopathy?

Journal Title: Archives of Medical Science - Year 2008, Vol 4, Issue 2

Abstract

Authors and Affiliations

Aleksandra Araszkiewicz, Dorota Zozulińska-Ziółkiewicz, Magdalena Trepińska, Bogna Wierusz-Wysocka

Keywords

Related Articles

The interaction of coronary microembolization and ischemic preconditioning: A third window of cardioprotection through TNF-alpha

With an unstable atherosclerotic coronary plaque, episodes of myocardial ischemia associated with release of debris and microembolization and subsequent restoration of more or less sufficient coronary blood flow can prec...

Evaluation of prophylaxis using low doses of heparin associated with aspirin in pregnancy with multiple miscarriages and high antiphospholipid antibody levels - preliminary report

Introduction: Gestation constitutes a state of acquired hypercoagulability and the success of a pregnancy depends on an adequate placental blood circulation. The objective of this study was to evaluate the evolution of p...

Download PDF file
  • EP ID EP96708
  • DOI -
  • Views 167
  • Downloads 0

How To Cite

Aleksandra Araszkiewicz, Dorota Zozulińska-Ziółkiewicz, Magdalena Trepińska, Bogna Wierusz-Wysocka (2008). Why does intensive insulin therapy implemented at the onset of type 1 diabetes not decrease prevalence of diabetic microangiopathy?. Archives of Medical Science, 4(2), 167-173. https://europub.co.uk/articles/-A-96708